A Snapshot Audit of Traumatic Pelvic Ring Injuries
Launched by UNIVERSITY HOSPITAL, AACHEN · Aug 5, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the 'ESTES snapshot audit,' is studying traumatic pelvic ring injuries, which can happen due to various types of trauma. These injuries are common in both younger people, often from serious accidents, and older adults, usually from falls. The goal of this study is to gather information from different hospitals across Europe to understand how these injuries are treated and to identify any differences in care practices. By examining these variations, the researchers hope to generate new ideas for future studies that could improve patient care.
To participate in this trial, individuals must be at least 18 years old and have been admitted to the hospital for a traumatic pelvic ring injury. However, those with additional fractures in the hip area will not be included. Participants can expect that their treatment approaches and outcomes will be closely observed and recorded, helping to provide a clearer picture of how pelvic injuries are managed in real-world settings. This information will not only help improve care for current patients but could also guide better practices in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥18 years of age) admitted for traumatic pelvic ring injuries (AO/FFP-Classification).
- Exclusion Criteria:
- • Concomitant acetabular fractures
About University Hospital, Aachen
The University Hospital Aachen, renowned for its commitment to advancing medical research and patient care, serves as a leading clinical trial sponsor dedicated to fostering innovative healthcare solutions. With a robust infrastructure and a multidisciplinary team of experts, the hospital engages in a wide range of clinical studies, striving to translate cutting-edge scientific discoveries into effective treatments. Its strategic collaborations with academic institutions and industry partners further enhance its capacity to conduct rigorous trials, ensuring adherence to the highest ethical standards and regulatory compliance. Through its pioneering efforts, the University Hospital Aachen aims to improve patient outcomes and contribute significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Frank Hildebrand, Prof. Dr.
Study Chair
University Hospital, Aachen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported